BioSpace News Archive

Hesperos, Inc., announced today the receipt of a NIH Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) National Institute on Aging (NIA) to help create a new multi-organ “human-on-a-chip” model that can realistically mimic the biology of Alzheimer’s Disease (AD) and the effects of potential new therapies under realistic human physiological conditions.

UPM Pharmaceuticals, a Contract Development and Manufacturing Organization (CDMO) focused on oral solid and semi-solid drug dosage forms, has appointed Dr. Chi-Chang Wung to the position of Director of Analytical Development. Dr. Wung will oversee UPM’s analytical development group.

Surgeons specializing in breast cancer can now receive training in advanced oncoplastic procedures from the School of Oncoplastic Surgery (SOS).

Taking place in August, National ASC Month serves to promote awareness of the safe, affordable, exceptional care that ASCs provide.

Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative therapeutics for dogs and cats, plans on presenting at CL King & Associates Best Ideas Conference on Thursday, September 13, 2018 at 1:15 p.m. ET in New York City.

Amgen (NASDAQ:AMGN) today announced that the European Commission (EC) has approved an expanded indication for BLINCYTO® (blinatumomab) as monotherapy for the treatment of pediatric patients aged one year or older with Philadelphia chromosome-negative CD19 positive B-cell precursor acute lymphoblastic leukemia

BRONX, N.Y., /PRNewswire/ -- On Friday, August 24, 2018, Assemblymember Victor M. Pichardo (NY-86) toured the Mid-Bronx Endoscopy Center (MBEC) to mark National Ambulatory Surgery Center Month.

DISH and Independa, the global leader in remote engagement technologies, are transforming the way people interact with entertainment and healthcare services, whether at home or in senior living communities

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 13th Annual Wells Fargo Securities Healthcare Conference on Wednesday, September 5, 2018 in Boston.

Valent BioSciences (VBC), the global leader in biorational solutions for public health, forest health, and agriculture, announced it has entered into a strategic partnership with ADAPCO, the world’s largest distributor of products to the professional mosquito control industry.